Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed repair of 15-year inferior rectus entrapment.

Orbit (Amsterdam, Netherlands)·2026
Same author

Ultrasound biomicroscopy and anterior segment OCT in ocular surface squamous neoplasia: complementary roles, case series, and targeted literature review.

Frontiers in ophthalmology·2026
Same author

Multimodal Imaging of Globe Compression Caused by a Displaced Orbital Fracture.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Orbital masses: a review of CT imaging characteristics.

Frontiers in ophthalmology·2025
Same author

Association Between Acquired Punctal Stenosis and Ocular Surface Disease: the Egg and the Chicken Story.

Seminars in ophthalmology·2024
Same author

Semiautomated MRI-Based Method for Orbital Volume and Contour Analysis.

Ophthalmic plastic and reconstructive surgery·2024

Related Experiment Videos

An augmented trabeculectomy for neovascular glaucoma.

Elie Dahan1, Guy J Ben Simon

  • 1Department of Ophthalmology, Oxford Eye Center, University of Witwatersrand, Johannesburg, South Africa.

Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye
|May 14, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces a new surgical technique for neovascular glaucoma (NVG) that effectively lowers intraocular pressure (IOP). Surgical revisions were needed in 50% of patients to maintain target IOP without glaucoma medications.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Research

Background:

  • Neovascular glaucoma (NVG) presents significant challenges in managing intraocular pressure (IOP).
  • Proliferative diabetic retinopathy and retinal vein occlusion are common causes of NVG.
  • Effective surgical interventions are crucial for preserving vision in NVG patients.

Purpose of the Study:

  • To present a novel surgical technique for treating neovascular glaucoma (NVG).
  • To evaluate the efficacy of an augmented trabeculectomy with mitomycin C and a hydrophilic implant in NVG patients.

Main Methods:

  • Fourteen eyes with NVG underwent augmented trabeculectomy using a specific scleral flap, deep sclerectomy, mitomycin C (MMC) application, and a T-flux hydrophilic implant.
  • The procedure aimed to connect the posterior chamber to the deep sclerectomy via a peripheral iridectomy.
  • Surgical revisions were performed if IOP exceeded 20 mm Hg, with repeat MMC application.

Main Results:

  • Mean IOP significantly decreased from 38.7 mmHg preoperatively to 17.3 mmHg postoperatively after a mean follow-up of 32 months (P=.001).
  • Mean visual acuity improved from 20/350 to 20/170 (P=.034).
  • Fifty percent of eyes required one surgical revision and 7% required two revisions within three months to maintain IOP below 21 mmHg.

Conclusions:

  • The modified trabeculectomy, enhanced with MMC and a T-flux wick drain, offers adequate IOP control for NVG secondary to proliferative diabetic retinopathy or retinal vein occlusion.
  • Surgical revisions are frequently necessary (at least 50% of cases) to achieve and maintain target IOP without anti-glaucoma medications.